SHAANXI MEIBANG PHARMACEUTICAL GROUP financial statements, including revenue, expenses, profit, and loss

The total revenue of 605033 for the last quarter is 111.92 M CNY, and it's 42.89% lower compared to the previous quarter. The net income of Q3 24 is -4.15 M CNY.